Brooks CD - Search Results

1

Synthesis of indolylalkoxyiminoalkylcarboxylates as leukotriene biosynthesis inhibitors.

Kolasa T, Bhatia P, Brooks CD, Hulkower KI, Bouska JB, Harris RR, Bell RL. Kolasa T, et al. Among authors: brooks cd. Bioorg Med Chem. 1997 Mar;5(3):507-14. doi: 10.1016/s0968-0896(96)00265-9. Bioorg Med Chem. 1997. PMID: 9113329

2

(R)-(+)-N-[3-[5-[(4-fluorophenyl)methyl]-2-thienyl]-1-methyl- 2-propynyl]-N-hydroxyurea (ABT-761), a second-generation 5-lipoxygenase inhibitor.

Brooks CD, Stewart AO, Basha A, Bhatia P, Ratajczyk JD, Martin JG, Craig RA, Kolasa T, Bouska JB, Lanni C, et al. Brooks CD, et al. J Med Chem. 1995 Nov 24;38(24):4768-75. doi: 10.1021/jm00024a004. J Med Chem. 1995. PMID: 7490726

3

5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.

Bhatia PA, Brooks CD, Basha A, Ratajczyk JD, Gunn BP, Bouska JB, Lanni C, Young PR, Bell RL, Carter GW. Bhatia PA, et al. Among authors: brooks cd. J Med Chem. 1996 Sep 27;39(20):3938-50. doi: 10.1021/jm960372b. J Med Chem. 1996. PMID: 8831760

4

Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors.

Kolasa T, Brooks CD, Rodriques KE, Summers JB, Dellaria JF, Hulkower KI, Bouska J, Bell RL, Carter GW. Kolasa T, et al. Among authors: brooks cd. J Med Chem. 1997 Feb 28;40(5):819-24. doi: 10.1021/jm9606150. J Med Chem. 1997. PMID: 9057869

5

Conversion of cyclooxygenase inhibitors into hydroxythiazole 5-lipoxygenase inhibitors.

Kerdesky FA, Brooks CD, Hulkower KI, Bouska JB, Bell RL. Kerdesky FA, et al. Among authors: brooks cd. Bioorg Med Chem. 1997 Feb;5(2):393-6. doi: 10.1016/s0968-0896(96)00255-6. Bioorg Med Chem. 1997. PMID: 9061203

6

Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitors.

Stewart AO, Bhatia PA, Martin JG, Summers JB, Rodriques KE, Martin MB, Holms JH, Moore JL, Craig RA, Kolasa T, Ratajczyk JD, Mazdiyasni H, Kerdesky FA, DeNinno SL, Maki RG, Bouska JB, Young PR, Lanni C, Bell RL, Carter GW, Brooks CD. Stewart AO, et al. Among authors: brooks cd. J Med Chem. 1997 Jun 20;40(13):1955-68. doi: 10.1021/jm9700474. J Med Chem. 1997. PMID: 9207936

7

Characterization of A-93178, an iminoxy-quinoline inhibitor of leukotriene biosynthesis.

Bell RL, Harris RR, Bouska JB, Hulkower KI, Moore J, Bhatia P, Malo PE, Kalosa T, Brooks CD, Carter GW. Bell RL, et al. Among authors: brooks cd. Adv Exp Med Biol. 1997;433:91-4. doi: 10.1007/978-1-4899-1810-9_18. Adv Exp Med Biol. 1997. PMID: 9561111 No abstract available.

8

Heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic acids as leukotriene biosynthesis inhibitors.

Kolasa T, Gunn DE, Bhatia P, Woods KW, Gane T, Stewart AO, Bouska JB, Harris RR, Hulkower KI, Malo PE, Bell RL, Carter GW, Brooks CD. Kolasa T, et al. Among authors: brooks cd. J Med Chem. 2000 Feb 24;43(4):690-705. doi: 10.1021/jm9904102. J Med Chem. 2000. PMID: 10691695

9

Symmetrical bis(heteroarylmethoxyphenyl)alkylcarboxylic acids as inhibitors of leukotriene biosynthesis.

Kolasa T, Gunn DE, Bhatia P, Basha A, Craig RA, Stewart AO, Bouska JB, Harris RR, Hulkower KI, Malo PE, Bell RL, Carter GW, Brooks CD. Kolasa T, et al. Among authors: brooks cd. J Med Chem. 2000 Aug 24;43(17):3322-34. doi: 10.1021/jm000180n. J Med Chem. 2000. PMID: 10966751

10

Leukotrienes do not regulate nitric oxide production in RAW 264.7 macrophages.

Hulkower KI, Pollock JS, Walsh RE, Huang R, Otis ER, Brooks CD, Bell RL. Hulkower KI, et al. Among authors: brooks cd. Prostaglandins Leukot Essent Fatty Acids. 1996 Sep;55(3):145-9. doi: 10.1016/s0952-3278(96)90089-7. Prostaglandins Leukot Essent Fatty Acids. 1996. PMID: 8931110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters